Shanghai Immune Therapy Institute

Located in the center of Shanghai Pudong District, Shanghai Immune Therapy Institute (SITI) is a newly established research institute affiliated with Renji Hospital, Shanghai Jiao Tong University School of Medicine led by world-renowned immunologist Chen Dong. The institute aims to pursue basic- and clinical-orientated innovative research in tumor immunotherapy, chronic inflammatory diseases, transplantation, infectious diseases, and vaccine development. By the year 2035, SITI aims to establish itself as a global leader in research areas encompassing new drug targets, novel mechanisms, antibody drug development, immunotherapy, and other significant immune-related diseases.

SITI currently has 11 research groups led by principal investigators (PIs) recruited from around the world and 9 PIs are national talents (including national youth talents). As the main member unit of National Key Laboratory of Innovative Immunotherapy, SITI provides substantial ongoing support and an open and vibrant environment for scientific research innovation.

Linkhttps://siti.renji.com:10443/

The sub forums organized

                             
Sub-Forum on Frontiers in Oncology and Immunology
Forum time: October 10, 2025
View